Page last updated: 2024-09-05

sorafenib and Cyst

sorafenib has been researched along with Cyst in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fabris, L; Ferrero, C; Fiorotto, R; Kim, AK; Locatelli, L; Morell, CM; Okolicsanyi, S; Spirli, C; Strazzabosco, M	1

Other Studies

1 other study(ies) available for sorafenib and Cyst

Article	Year
Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib. Hepatology (Baltimore, Md.), 2012, Volume: 56, Issue:6 Topics: Animals; Antineoplastic Agents, Hormonal; Benzenesulfonates; Bile Ducts; Caspase 3; Cell Proliferation; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Cysts; Drug Therapy, Combination; Epithelial Cells; Ki-67 Antigen; Liver Diseases; MAP Kinase Signaling System; Mice; Mice, Knockout; Niacinamide; Octreotide; Phenylurea Compounds; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-raf; Pyridines; Sorafenib; TRPP Cation Channels	2012

Article

Year

Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib.

Hepatology (Baltimore, Md.), 2012, Volume: 56, Issue:6

Topics: Animals; Antineoplastic Agents, Hormonal; Benzenesulfonates; Bile Ducts; Caspase 3; Cell Proliferation; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Cysts; Drug Therapy, Combination; Epithelial Cells; Ki-67 Antigen; Liver Diseases; MAP Kinase Signaling System; Mice; Mice, Knockout; Niacinamide; Octreotide; Phenylurea Compounds; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-raf; Pyridines; Sorafenib; TRPP Cation Channels

2012